These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23603557)

  • 21. 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
    Huang M; Horiguchi M; Felix AR; Meltzer HY
    Neuroreport; 2012 May; 23(7):436-40. PubMed ID: 22415605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D1 receptor modulation of set shifting: the role of stress exposure.
    Nikiforuk A
    Behav Pharmacol; 2012 Aug; 23(4):434-8. PubMed ID: 22743605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity.
    Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR
    Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
    Pedersen CS; Goetghebeur P; Dias R
    J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naltrexone reverses age-induced cognitive deficits in rats.
    Rodefer JS; Nguyen TN
    Neurobiol Aging; 2008 Feb; 29(2):309-13. PubMed ID: 17098330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examination of the mechanisms underlying the discriminative stimulus properties of the atypical antipsychotic amisulpride.
    Donahue TJ; Hillhouse TM; Webster KA; Young R; De Oliveira EO; Porter JH
    Behav Pharmacol; 2024 Feb; 35(1):47-54. PubMed ID: 38375659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT7 receptors and tryptophan hydroxylase in lymphocytes of rats: mitogen activation, physical restraint or treatment with reserpine.
    Urbina M; Arroyo R; Lima L
    Neuroimmunomodulation; 2014; 21(5):240-9. PubMed ID: 24603678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents.
    Gacsályi I; Nagy K; Pallagi K; Lévay G; Hársing LG; Móricz K; Kertész S; Varga P; Haller J; Gigler G; Szénási G; Barkóczy J; Bíró J; Spedding M; Antoni FA
    Neuropharmacology; 2013 Jan; 64():254-63. PubMed ID: 22824189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner.
    Nikiforuk A; Kos T; Rafa D; Behl B; Bespalov A; Popik P
    Neuropharmacology; 2011; 61(1-2):262-7. PubMed ID: 21530555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possible involvement of 5-HT₇ receptor in pathophysiology of affective disorders and action of antidepressant drugs].
    Tokarski K; Kusek M; Sowa J; Bobula B
    Postepy Hig Med Dosw (Online); 2014 Sep; 68():1104-13. PubMed ID: 25228519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of the 5-HT(6) receptor agonist EMD and the 5-HT(7) receptor agonist AS19 on memory formation.
    Meneses A; Perez-Garcia G; Liy-Salmeron G; Flores-Galvez D; Castillo C; Castillo E
    Behav Brain Res; 2008 Dec; 195(1):112-9. PubMed ID: 18191236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotics--effects of amisulpride on salivary secretion and on clozapine-induced sialorrhea.
    Godoy T; Riva A; Ekström J
    Oral Dis; 2012 Oct; 18(7):680-91. PubMed ID: 22458406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choline acetyltransferase expression in rat prefrontal cortex and hippocampus after acute and chronic exposure to amisulpride, haloperidol, and risperidone.
    Huang GB; Zhao T; Li CR; Sui ZY; Kang NI; Han EH; Chung YC
    Neurosci Lett; 2012 Oct; 528(2):131-6. PubMed ID: 22999925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
    Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C
    Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.
    Herrera-Estrella M; Apiquian R; Fresan A; Sanchez-Torres I
    BMC Psychiatry; 2005 May; 5():22. PubMed ID: 15869707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability.
    Lapiz MD; Morilak DA
    Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of serotonin receptors in the action of atypical antipsychotic drugs.
    Meltzer HY; Massey BW
    Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of 5-HT₇ receptors in the pathogenesis of temporal lobe epilepsy.
    Yang Z; Liu X; Yin Y; Sun S; Deng X
    Eur J Pharmacol; 2012 Jun; 685(1-3):52-8. PubMed ID: 22543085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.